Sign in

CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company

ATOSSA THERAPEUTICS, INC.

Sign in to watch
Ticker
ATOS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
264753208
Phone
206.588.0256
Business address
1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
Former names
ATOSSA GENETICS INC
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Bylaws or fiscal year change
  3. SC 13D Stake Beneficial Ownership Report
  4. CT ORDER Other Confidential Order
  5. 424B4 Offering Prospectus
  6. CERTNAS Other Certification by the Nasdaq Stock Market
  7. EFFECT Other Notice of Effectiveness
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. S-1/A Offering Registration Statement
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. S-1/A Offering Registration Statement

Page 30 of 33 · 643 filings